nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—HSPA1A—prostate cancer	0.344	0.718	CbGaD
Adenosine triphosphate—AKT1—prostate cancer	0.135	0.282	CbGaD
Adenosine triphosphate—ABCB11—Ethinyl Estradiol—prostate cancer	0.0518	0.234	CbGbCtD
Adenosine triphosphate—ABCC2—Ethinyl Estradiol—prostate cancer	0.0273	0.123	CbGbCtD
Adenosine triphosphate—ABCC2—Conjugated Estrogens—prostate cancer	0.02	0.0905	CbGbCtD
Adenosine triphosphate—ABCB1—Estramustine—prostate cancer	0.0155	0.07	CbGbCtD
Adenosine triphosphate—ABCB11—Doxorubicin—prostate cancer	0.0149	0.0673	CbGbCtD
Adenosine triphosphate—ABCC2—Etoposide—prostate cancer	0.0115	0.0519	CbGbCtD
Adenosine triphosphate—ABCC2—Docetaxel—prostate cancer	0.0105	0.0475	CbGbCtD
Adenosine triphosphate—ABCB1—Cabazitaxel—prostate cancer	0.0102	0.0461	CbGbCtD
Adenosine triphosphate—ABCB1—Estrone—prostate cancer	0.00997	0.0451	CbGbCtD
Adenosine triphosphate—ABCB1—Ethinyl Estradiol—prostate cancer	0.00889	0.0402	CbGbCtD
Adenosine triphosphate—ABCC2—Doxorubicin—prostate cancer	0.00782	0.0354	CbGbCtD
Adenosine triphosphate—ABCB1—Conjugated Estrogens—prostate cancer	0.00652	0.0295	CbGbCtD
Adenosine triphosphate—ABCB1—Mitoxantrone—prostate cancer	0.00593	0.0268	CbGbCtD
Adenosine triphosphate—ABCB1—Estradiol—prostate cancer	0.00573	0.0259	CbGbCtD
Adenosine triphosphate—ABCB1—Prednisone—prostate cancer	0.00492	0.0223	CbGbCtD
Adenosine triphosphate—ABCB1—Etoposide—prostate cancer	0.00374	0.0169	CbGbCtD
Adenosine triphosphate—ABCB1—Docetaxel—prostate cancer	0.00342	0.0155	CbGbCtD
Adenosine triphosphate—AKT1—penis—prostate cancer	0.00292	0.027	CbGeAlD
Adenosine triphosphate—ABCB1—Doxorubicin—prostate cancer	0.00255	0.0115	CbGbCtD
Adenosine triphosphate—CDK15—prostate gland—prostate cancer	0.00229	0.0212	CbGeAlD
Adenosine triphosphate—ABCC8—penis—prostate cancer	0.00206	0.0191	CbGeAlD
Adenosine triphosphate—APAF1—prostate gland—prostate cancer	0.00204	0.0189	CbGeAlD
Adenosine triphosphate—ADRBK2—prostate gland—prostate cancer	0.00143	0.0133	CbGeAlD
Adenosine triphosphate—ACVRL1—prostate gland—prostate cancer	0.0013	0.012	CbGeAlD
Adenosine triphosphate—ABCG1—prostate gland—prostate cancer	0.0013	0.012	CbGeAlD
Adenosine triphosphate—ABCC9—prostate gland—prostate cancer	0.00124	0.0114	CbGeAlD
Adenosine triphosphate—HSPA1B—prostate gland—prostate cancer	0.00121	0.0112	CbGeAlD
Adenosine triphosphate—HSPA1A—prostate gland—prostate cancer	0.00121	0.0112	CbGeAlD
Adenosine triphosphate—S-Adenosylmethionine—GNMT—prostate cancer	0.00118	0.357	CrCbGaD
Adenosine triphosphate—ARAF—prostate gland—prostate cancer	0.00113	0.0105	CbGeAlD
Adenosine triphosphate—ACVR1B—prostate gland—prostate cancer	0.0011	0.0102	CbGeAlD
Adenosine triphosphate—ACVRL1—seminal vesicle—prostate cancer	0.0011	0.0102	CbGeAlD
Adenosine triphosphate—ABCG1—seminal vesicle—prostate cancer	0.0011	0.0102	CbGeAlD
Adenosine triphosphate—ASNA1—prostate gland—prostate cancer	0.00106	0.00985	CbGeAlD
Adenosine triphosphate—AFG3L2—prostate gland—prostate cancer	0.00105	0.00972	CbGeAlD
Adenosine triphosphate—HSPA1B—seminal vesicle—prostate cancer	0.00103	0.00949	CbGeAlD
Adenosine triphosphate—HSPA1A—seminal vesicle—prostate cancer	0.00103	0.00949	CbGeAlD
Adenosine triphosphate—NAE1—prostate gland—prostate cancer	0.00103	0.00949	CbGeAlD
Adenosine triphosphate—CDK15—testis—prostate cancer	0.00101	0.00933	CbGeAlD
Adenosine triphosphate—ARAF—seminal vesicle—prostate cancer	0.00096	0.00888	CbGeAlD
Adenosine triphosphate—ACVRL1—epithelium—prostate cancer	0.000955	0.00884	CbGeAlD
Adenosine triphosphate—SLC25A4—prostate gland—prostate cancer	0.000955	0.00884	CbGeAlD
Adenosine triphosphate—TNK2—prostate gland—prostate cancer	0.000937	0.00867	CbGeAlD
Adenosine triphosphate—AMHR2—testis—prostate cancer	0.00093	0.00861	CbGeAlD
Adenosine triphosphate—ASNA1—seminal vesicle—prostate cancer	0.0009	0.00833	CbGeAlD
Adenosine triphosphate—APAF1—testis—prostate cancer	0.000899	0.00832	CbGeAlD
Adenosine triphosphate—AFG3L2—seminal vesicle—prostate cancer	0.000889	0.00822	CbGeAlD
Adenosine triphosphate—ACVRL1—urethra—prostate cancer	0.00087	0.00806	CbGeAlD
Adenosine triphosphate—ABCG1—urethra—prostate cancer	0.00087	0.00806	CbGeAlD
Adenosine triphosphate—NAE1—seminal vesicle—prostate cancer	0.000867	0.00802	CbGeAlD
Adenosine triphosphate—ADRBK1—prostate gland—prostate cancer	0.000847	0.00784	CbGeAlD
Adenosine triphosphate—ACSS1—prostate gland—prostate cancer	0.000847	0.00784	CbGeAlD
Adenosine triphosphate—ABCA1—prostate gland—prostate cancer	0.000838	0.00775	CbGeAlD
Adenosine triphosphate—NT5C2—prostate gland—prostate cancer	0.000829	0.00767	CbGeAlD
Adenosine triphosphate—ACVR1—prostate gland—prostate cancer	0.000829	0.00767	CbGeAlD
Adenosine triphosphate—HSPA1B—urethra—prostate cancer	0.000812	0.00752	CbGeAlD
Adenosine triphosphate—HSPA1A—urethra—prostate cancer	0.000812	0.00752	CbGeAlD
Adenosine triphosphate—ACSS2—prostate gland—prostate cancer	0.000812	0.00751	CbGeAlD
Adenosine triphosphate—ACSL1—prostate gland—prostate cancer	0.000807	0.00747	CbGeAlD
Adenosine triphosphate—ABL2—prostate gland—prostate cancer	0.000791	0.00732	CbGeAlD
Adenosine triphosphate—ARAF—renal system—prostate cancer	0.000773	0.00716	CbGeAlD
Adenosine triphosphate—PRKAA1—prostate gland—prostate cancer	0.000763	0.00707	CbGeAlD
Adenosine triphosphate—ARAF—urethra—prostate cancer	0.00076	0.00703	CbGeAlD
Adenosine triphosphate—ACVR1B—renal system—prostate cancer	0.000751	0.00695	CbGeAlD
Adenosine triphosphate—Azacitidine—DNMT1—prostate cancer	0.000749	0.227	CrCbGaD
Adenosine triphosphate—ADRBK2—bone marrow—prostate cancer	0.000739	0.00683	CbGeAlD
Adenosine triphosphate—HSPA1A—Paclitaxel—Cabazitaxel—prostate cancer	0.000726	0.214	CbGdCrCtD
Adenosine triphosphate—ASNA1—renal system—prostate cancer	0.000725	0.00671	CbGeAlD
Adenosine triphosphate—ACSS1—seminal vesicle—prostate cancer	0.000716	0.00663	CbGeAlD
Adenosine triphosphate—AFG3L2—renal system—prostate cancer	0.000716	0.00663	CbGeAlD
Adenosine triphosphate—ASNA1—urethra—prostate cancer	0.000713	0.0066	CbGeAlD
Adenosine triphosphate—AFG3L2—urethra—prostate cancer	0.000704	0.00651	CbGeAlD
Adenosine triphosphate—ACVR1—seminal vesicle—prostate cancer	0.000701	0.00649	CbGeAlD
Adenosine triphosphate—NT5C2—seminal vesicle—prostate cancer	0.000701	0.00649	CbGeAlD
Adenosine triphosphate—NAE1—renal system—prostate cancer	0.000699	0.00647	CbGeAlD
Adenosine triphosphate—ASNS—prostate gland—prostate cancer	0.000697	0.00645	CbGeAlD
Adenosine triphosphate—AKT1—prostate gland—prostate cancer	0.000697	0.00645	CbGeAlD
Adenosine triphosphate—ACSS2—seminal vesicle—prostate cancer	0.000687	0.00636	CbGeAlD
Adenosine triphosphate—NAE1—urethra—prostate cancer	0.000686	0.00635	CbGeAlD
Adenosine triphosphate—ACSL1—seminal vesicle—prostate cancer	0.000682	0.00631	CbGeAlD
Adenosine triphosphate—AMHR2—lymph node—prostate cancer	0.000674	0.00624	CbGeAlD
Adenosine triphosphate—APAF1—lymph node—prostate cancer	0.000651	0.00603	CbGeAlD
Adenosine triphosphate—SLC25A4—renal system—prostate cancer	0.000651	0.00602	CbGeAlD
Adenosine triphosphate—ADRBK2—testis—prostate cancer	0.000631	0.00584	CbGeAlD
Adenosine triphosphate—HSPA1B—bone marrow—prostate cancer	0.000625	0.00578	CbGeAlD
Adenosine triphosphate—HSPA1A—bone marrow—prostate cancer	0.000625	0.00578	CbGeAlD
Adenosine triphosphate—ASS1—prostate gland—prostate cancer	0.000607	0.00562	CbGeAlD
Adenosine triphosphate—AKT1—seminal vesicle—prostate cancer	0.000589	0.00545	CbGeAlD
Adenosine triphosphate—ASNS—seminal vesicle—prostate cancer	0.000589	0.00545	CbGeAlD
Adenosine triphosphate—ARAF—bone marrow—prostate cancer	0.000585	0.00541	CbGeAlD
Adenosine triphosphate—ADRBK1—renal system—prostate cancer	0.000577	0.00534	CbGeAlD
Adenosine triphosphate—ACSS1—renal system—prostate cancer	0.000577	0.00534	CbGeAlD
Adenosine triphosphate—ABCG1—testis—prostate cancer	0.000573	0.0053	CbGeAlD
Adenosine triphosphate—ACVRL1—testis—prostate cancer	0.000573	0.0053	CbGeAlD
Adenosine triphosphate—ABCA1—renal system—prostate cancer	0.000571	0.00528	CbGeAlD
Adenosine triphosphate—ACSS1—urethra—prostate cancer	0.000567	0.00525	CbGeAlD
Adenosine triphosphate—ACVR1—renal system—prostate cancer	0.000565	0.00523	CbGeAlD
Adenosine triphosphate—NT5C2—renal system—prostate cancer	0.000565	0.00523	CbGeAlD
Adenosine triphosphate—ADCY1—testis—prostate cancer	0.000555	0.00514	CbGeAlD
Adenosine triphosphate—NT5C2—urethra—prostate cancer	0.000555	0.00514	CbGeAlD
Adenosine triphosphate—ACVR1—urethra—prostate cancer	0.000555	0.00514	CbGeAlD
Adenosine triphosphate—ACSS2—renal system—prostate cancer	0.000553	0.00512	CbGeAlD
Adenosine triphosphate—ACSL1—renal system—prostate cancer	0.00055	0.00509	CbGeAlD
Adenosine triphosphate—ASNA1—bone marrow—prostate cancer	0.000549	0.00508	CbGeAlD
Adenosine triphosphate—ABCC9—testis—prostate cancer	0.000544	0.00504	CbGeAlD
Adenosine triphosphate—ACSS2—urethra—prostate cancer	0.000544	0.00503	CbGeAlD
Adenosine triphosphate—AFG3L2—bone marrow—prostate cancer	0.000541	0.00501	CbGeAlD
Adenosine triphosphate—ACSL1—urethra—prostate cancer	0.00054	0.005	CbGeAlD
Adenosine triphosphate—HSPA1B—testis—prostate cancer	0.000534	0.00495	CbGeAlD
Adenosine triphosphate—HSPA1A—testis—prostate cancer	0.000534	0.00495	CbGeAlD
Adenosine triphosphate—ADK—prostate gland—prostate cancer	0.00053	0.00491	CbGeAlD
Adenosine triphosphate—NAE1—bone marrow—prostate cancer	0.000528	0.00489	CbGeAlD
Adenosine triphosphate—PRKAA1—renal system—prostate cancer	0.00052	0.00482	CbGeAlD
Adenosine triphosphate—ASS1—seminal vesicle—prostate cancer	0.000514	0.00475	CbGeAlD
Adenosine triphosphate—AKT1—epithelium—prostate cancer	0.000512	0.00474	CbGeAlD
Adenosine triphosphate—ARAF—testis—prostate cancer	0.0005	0.00463	CbGeAlD
Adenosine triphosphate—ABCC8—prostate gland—prostate cancer	0.000492	0.00455	CbGeAlD
Adenosine triphosphate—ACVR1B—testis—prostate cancer	0.000485	0.00449	CbGeAlD
Adenosine triphosphate—AKT1—renal system—prostate cancer	0.000475	0.00439	CbGeAlD
Adenosine triphosphate—ASNA1—testis—prostate cancer	0.000469	0.00434	CbGeAlD
Adenosine triphosphate—AKT1—urethra—prostate cancer	0.000466	0.00432	CbGeAlD
Adenosine triphosphate—ASNS—urethra—prostate cancer	0.000466	0.00432	CbGeAlD
Adenosine triphosphate—AFG3L2—testis—prostate cancer	0.000463	0.00428	CbGeAlD
Adenosine triphosphate—ADRBK2—lymph node—prostate cancer	0.000458	0.00424	CbGeAlD
Adenosine triphosphate—NAE1—testis—prostate cancer	0.000452	0.00418	CbGeAlD
Adenosine triphosphate—ADK—seminal vesicle—prostate cancer	0.000449	0.00415	CbGeAlD
Adenosine triphosphate—ASS1—epithelium—prostate cancer	0.000446	0.00413	CbGeAlD
Adenosine triphosphate—ADRBK1—bone marrow—prostate cancer	0.000436	0.00404	CbGeAlD
Adenosine triphosphate—ACSS1—bone marrow—prostate cancer	0.000436	0.00404	CbGeAlD
Adenosine triphosphate—ALK—testis—prostate cancer	0.000429	0.00397	CbGeAlD
Adenosine triphosphate—ACVR1—bone marrow—prostate cancer	0.000427	0.00395	CbGeAlD
Adenosine triphosphate—NT5C2—bone marrow—prostate cancer	0.000427	0.00395	CbGeAlD
Adenosine triphosphate—SLC25A4—testis—prostate cancer	0.000421	0.00389	CbGeAlD
Adenosine triphosphate—ACSS2—bone marrow—prostate cancer	0.000418	0.00387	CbGeAlD
Adenosine triphosphate—ABCC8—seminal vesicle—prostate cancer	0.000416	0.00385	CbGeAlD
Adenosine triphosphate—ACSL1—bone marrow—prostate cancer	0.000416	0.00385	CbGeAlD
Adenosine triphosphate—ABCG1—lymph node—prostate cancer	0.000415	0.00384	CbGeAlD
Adenosine triphosphate—ACVRL1—lymph node—prostate cancer	0.000415	0.00384	CbGeAlD
Adenosine triphosphate—ASS1—renal system—prostate cancer	0.000414	0.00383	CbGeAlD
Adenosine triphosphate—TNK2—testis—prostate cancer	0.000413	0.00382	CbGeAlD
Adenosine triphosphate—ASS1—urethra—prostate cancer	0.000407	0.00376	CbGeAlD
Adenosine triphosphate—ADCY1—lymph node—prostate cancer	0.000402	0.00372	CbGeAlD
Adenosine triphosphate—ABCC9—lymph node—prostate cancer	0.000395	0.00365	CbGeAlD
Adenosine triphosphate—PRKAA1—bone marrow—prostate cancer	0.000393	0.00364	CbGeAlD
Adenosine triphosphate—HSPA1B—lymph node—prostate cancer	0.000387	0.00358	CbGeAlD
Adenosine triphosphate—HSPA1A—lymph node—prostate cancer	0.000387	0.00358	CbGeAlD
Adenosine triphosphate—Flavin adenine dinucleotide—NQO1—prostate cancer	0.000383	0.116	CrCbGaD
Adenosine triphosphate—ABL1—prostate gland—prostate cancer	0.000382	0.00353	CbGeAlD
Adenosine triphosphate—ADRBK1—testis—prostate cancer	0.000373	0.00345	CbGeAlD
Adenosine triphosphate—ACSS1—testis—prostate cancer	0.000373	0.00345	CbGeAlD
Adenosine triphosphate—ABCA1—testis—prostate cancer	0.000369	0.00342	CbGeAlD
Adenosine triphosphate—ACVR1—testis—prostate cancer	0.000365	0.00338	CbGeAlD
Adenosine triphosphate—NT5C2—testis—prostate cancer	0.000365	0.00338	CbGeAlD
Adenosine triphosphate—ARAF—lymph node—prostate cancer	0.000362	0.00335	CbGeAlD
Adenosine triphosphate—ADK—renal system—prostate cancer	0.000362	0.00335	CbGeAlD
Adenosine triphosphate—AKT1—bone marrow—prostate cancer	0.000359	0.00332	CbGeAlD
Adenosine triphosphate—ASNS—bone marrow—prostate cancer	0.000359	0.00332	CbGeAlD
Adenosine triphosphate—ACSS2—testis—prostate cancer	0.000358	0.00331	CbGeAlD
Adenosine triphosphate—ACSL1—testis—prostate cancer	0.000355	0.00329	CbGeAlD
Adenosine triphosphate—ADK—urethra—prostate cancer	0.000355	0.00329	CbGeAlD
Adenosine triphosphate—ACVR1B—lymph node—prostate cancer	0.000352	0.00325	CbGeAlD
Adenosine triphosphate—ABL2—testis—prostate cancer	0.000349	0.00323	CbGeAlD
Adenosine triphosphate—ASNA1—lymph node—prostate cancer	0.00034	0.00315	CbGeAlD
Adenosine triphosphate—NAE1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000339	0.0999	CbGdCrCtD
Adenosine triphosphate—PRKAA1—testis—prostate cancer	0.000336	0.00311	CbGeAlD
Adenosine triphosphate—AFG3L2—lymph node—prostate cancer	0.000336	0.00311	CbGeAlD
Adenosine triphosphate—ABCC8—renal system—prostate cancer	0.000335	0.0031	CbGeAlD
Adenosine triphosphate—ABCC2—prostate gland—prostate cancer	0.00033	0.00305	CbGeAlD
Adenosine triphosphate—NAE1—lymph node—prostate cancer	0.000327	0.00303	CbGeAlD
Adenosine triphosphate—ABL1—seminal vesicle—prostate cancer	0.000323	0.00299	CbGeAlD
Adenosine triphosphate—ALK—lymph node—prostate cancer	0.000311	0.00288	CbGeAlD
Adenosine triphosphate—AKT1—testis—prostate cancer	0.000307	0.00284	CbGeAlD
Adenosine triphosphate—ASNS—testis—prostate cancer	0.000307	0.00284	CbGeAlD
Adenosine triphosphate—SLC25A4—lymph node—prostate cancer	0.000305	0.00282	CbGeAlD
Adenosine triphosphate—S-Adenosylmethionine—COMT—prostate cancer	0.000302	0.0915	CrCbGaD
Adenosine triphosphate—HSPA1A—Paclitaxel—Docetaxel—prostate cancer	0.000301	0.0888	CbGdCrCtD
Adenosine triphosphate—TNK2—lymph node—prostate cancer	0.000299	0.00277	CbGeAlD
Adenosine triphosphate—Adenosine monophosphate—PDE4D—prostate cancer	0.000294	0.0891	CrCbGaD
Adenosine triphosphate—ABCB11—testis—prostate cancer	0.000286	0.00265	CbGeAlD
Adenosine triphosphate—ADK—bone marrow—prostate cancer	0.000273	0.00253	CbGeAlD
Adenosine triphosphate—ADRBK1—lymph node—prostate cancer	0.00027	0.0025	CbGeAlD
Adenosine triphosphate—ACSS1—lymph node—prostate cancer	0.00027	0.0025	CbGeAlD
Adenosine triphosphate—ASS1—testis—prostate cancer	0.000268	0.00248	CbGeAlD
Adenosine triphosphate—ABCA1—lymph node—prostate cancer	0.000268	0.00248	CbGeAlD
Adenosine triphosphate—NT5C2—lymph node—prostate cancer	0.000265	0.00245	CbGeAlD
Adenosine triphosphate—ACVR1—lymph node—prostate cancer	0.000265	0.00245	CbGeAlD
Adenosine triphosphate—ABL1—renal system—prostate cancer	0.00026	0.00241	CbGeAlD
Adenosine triphosphate—ACSS2—lymph node—prostate cancer	0.000259	0.0024	CbGeAlD
Adenosine triphosphate—ACSL1—lymph node—prostate cancer	0.000258	0.00238	CbGeAlD
Adenosine triphosphate—Adenosine monophosphate—SRC—prostate cancer	0.000257	0.0779	CrCbGaD
Adenosine triphosphate—ABL1—urethra—prostate cancer	0.000256	0.00237	CbGeAlD
Adenosine triphosphate—ABL2—lymph node—prostate cancer	0.000253	0.00234	CbGeAlD
Adenosine triphosphate—PRKAA1—lymph node—prostate cancer	0.000244	0.00226	CbGeAlD
Adenosine triphosphate—ADK—testis—prostate cancer	0.000234	0.00216	CbGeAlD
Adenosine triphosphate—ABCC2—renal system—prostate cancer	0.000225	0.00208	CbGeAlD
Adenosine triphosphate—ASNS—lymph node—prostate cancer	0.000222	0.00206	CbGeAlD
Adenosine triphosphate—AKT1—lymph node—prostate cancer	0.000222	0.00206	CbGeAlD
Adenosine triphosphate—ABCC8—testis—prostate cancer	0.000217	0.00201	CbGeAlD
Adenosine triphosphate—ABL1—bone marrow—prostate cancer	0.000197	0.00182	CbGeAlD
Adenosine triphosphate—ASS1—lymph node—prostate cancer	0.000194	0.00179	CbGeAlD
Adenosine triphosphate—HSPA1A—Podofilox—Etoposide—prostate cancer	0.000194	0.057	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Levorphanol—Estrone—prostate cancer	0.000192	0.0565	CbGdCrCtD
Adenosine triphosphate—ADK—lymph node—prostate cancer	0.000169	0.00157	CbGeAlD
Adenosine triphosphate—ABL1—testis—prostate cancer	0.000168	0.00156	CbGeAlD
Adenosine triphosphate—ABCC2—testis—prostate cancer	0.000145	0.00135	CbGeAlD
Adenosine triphosphate—HSPA1A—Levorphanol—Estradiol—prostate cancer	0.000145	0.0428	CbGdCrCtD
Adenosine triphosphate—ABL1—Levorphanol—Estrone—prostate cancer	0.000145	0.0428	CbGdCrCtD
Adenosine triphosphate—S-Adenosylmethionine—CYP2E1—prostate cancer	0.000141	0.0426	CrCbGaD
Adenosine triphosphate—ASS1—Norethindrone—Ethinyl Estradiol—prostate cancer	0.000129	0.0379	CbGdCrCtD
Adenosine triphosphate—ABL1—lymph node—prostate cancer	0.000122	0.00113	CbGeAlD
Adenosine triphosphate—ABCB1—prostate gland—prostate cancer	0.000119	0.0011	CbGeAlD
Adenosine triphosphate—ABL1—Levorphanol—Estradiol—prostate cancer	0.00011	0.0324	CbGdCrCtD
Adenosine triphosphate—ABCC2—lymph node—prostate cancer	0.000105	0.000975	CbGeAlD
Adenosine triphosphate—HSPA1A—Daunorubicin—Epirubicin—prostate cancer	0.000101	0.0297	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Idarubicin—Epirubicin—prostate cancer	0.000101	0.0297	CbGdCrCtD
Adenosine triphosphate—ABCB1—seminal vesicle—prostate cancer	0.0001	0.000929	CbGeAlD
Adenosine triphosphate—HSPA1A—Daunorubicin—Doxorubicin—prostate cancer	9.34e-05	0.0275	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Idarubicin—Doxorubicin—prostate cancer	9.34e-05	0.0275	CbGdCrCtD
Adenosine triphosphate—ABCB1—epithelium—prostate cancer	8.72e-05	0.000807	CbGeAlD
Adenosine triphosphate—ABCB1—renal system—prostate cancer	8.09e-05	0.000749	CbGeAlD
Adenosine triphosphate—ABCB1—urethra—prostate cancer	7.95e-05	0.000735	CbGeAlD
Adenosine triphosphate—ABL1—Idarubicin—Epirubicin—prostate cancer	7.65e-05	0.0225	CbGdCrCtD
Adenosine triphosphate—ABL1—Doxorubicin—Epirubicin—prostate cancer	7.65e-05	0.0225	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Epirubicin—prostate cancer	7.65e-05	0.0225	CbGdCrCtD
Adenosine triphosphate—ABL1—Epirubicin—Doxorubicin—prostate cancer	7.08e-05	0.0208	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Doxorubicin—prostate cancer	7.08e-05	0.0208	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Doxorubicin—prostate cancer	7.08e-05	0.0208	CbGdCrCtD
Adenosine triphosphate—ABCB1—bone marrow—prostate cancer	6.12e-05	0.000566	CbGeAlD
Adenosine triphosphate—ACVR1—Dexamethasone—Prednisone—prostate cancer	6.1e-05	0.0179	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Prednisone—prostate cancer	6.1e-05	0.0179	CbGdCrCtD
Adenosine triphosphate—ABCB1—testis—prostate cancer	5.23e-05	0.000484	CbGeAlD
Adenosine triphosphate—HSPA1A—Triamcinolone—Prednisone—prostate cancer	4.35e-05	0.0128	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Prednisone—prostate cancer	4.01e-05	0.0118	CbGdCrCtD
Adenosine triphosphate—ABCB1—lymph node—prostate cancer	3.79e-05	0.000351	CbGeAlD
Adenosine triphosphate—HSPA1A—Budesonide—Prednisone—prostate cancer	3.52e-05	0.0104	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Prednisone—prostate cancer	2.15e-05	0.00634	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Prednisone—prostate cancer	2.15e-05	0.00634	CbGdCrCtD
Adenosine triphosphate—ABCB1—Metabolism—SULT2A1—prostate cancer	1.03e-06	5.57e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.03e-06	5.57e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CDKN1B—prostate cancer	1.03e-06	5.56e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TERT—prostate cancer	1.03e-06	5.56e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PTEN—prostate cancer	1.03e-06	5.56e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NOS3—prostate cancer	1.03e-06	5.56e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PIK3CB—prostate cancer	1.03e-06	5.56e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—JAK2—prostate cancer	1.03e-06	5.55e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—IL6—prostate cancer	1.03e-06	5.53e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—PIK3CA—prostate cancer	1.02e-06	5.51e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—AKT1—prostate cancer	1.02e-06	5.5e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—BCL2—prostate cancer	1.02e-06	5.49e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—MED12—prostate cancer	1.02e-06	5.48e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CXCL8—prostate cancer	1.01e-06	5.46e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CASP3—prostate cancer	1.01e-06	5.45e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL2—prostate cancer	1.01e-06	5.45e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GNG5—prostate cancer	1.01e-06	5.44e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—IL6—prostate cancer	1.01e-06	5.42e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—MDM2—prostate cancer	1.01e-06	5.41e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—JAK2—prostate cancer	1e-06	5.4e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—KRAS—prostate cancer	1e-06	5.39e-06	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PTEN—prostate cancer	9.98e-07	5.37e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—PIK3CA—prostate cancer	9.95e-07	5.36e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ERBB2—prostate cancer	9.91e-07	5.34e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CDKN1B—prostate cancer	9.91e-07	5.33e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—NOS3—prostate cancer	9.89e-07	5.32e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—HIF1A—prostate cancer	9.88e-07	5.32e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCND1—prostate cancer	9.86e-07	5.31e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—INS—prostate cancer	9.85e-07	5.31e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EP300—prostate cancer	9.85e-07	5.3e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—AKT1—prostate cancer	9.8e-07	5.28e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MDM2—prostate cancer	9.79e-07	5.27e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PIK3CB—prostate cancer	9.78e-07	5.27e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CTNNB1—prostate cancer	9.76e-07	5.26e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NCOA3—prostate cancer	9.73e-07	5.24e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CASP3—prostate cancer	9.71e-07	5.23e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL2—prostate cancer	9.69e-07	5.22e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CDKN1B—prostate cancer	9.68e-07	5.21e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—CREBBP—prostate cancer	9.65e-07	5.2e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ERBB2—prostate cancer	9.65e-07	5.2e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—LEP—prostate cancer	9.65e-07	5.19e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—IL6—prostate cancer	9.64e-07	5.19e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PIK3CA—prostate cancer	9.58e-07	5.16e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—SRC—prostate cancer	9.58e-07	5.16e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MMP9—prostate cancer	9.57e-07	5.15e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—IL6—prostate cancer	9.56e-07	5.15e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CAV1—prostate cancer	9.56e-07	5.15e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CDKN1A—prostate cancer	9.53e-07	5.14e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PIK3CB—prostate cancer	9.52e-07	5.13e-06	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—EP300—prostate cancer	9.51e-07	5.12e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PTEN—prostate cancer	9.51e-07	5.12e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL2—prostate cancer	9.47e-07	5.1e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—AKT1—prostate cancer	9.47e-07	5.1e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCND1—prostate cancer	9.45e-07	5.09e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KDR—prostate cancer	9.45e-07	5.09e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTGS2—prostate cancer	9.44e-07	5.08e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CTNNB1—prostate cancer	9.36e-07	5.04e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—VEGFA—prostate cancer	9.33e-07	5.02e-06	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—AKT1—prostate cancer	9.31e-07	5.01e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—AKT1—prostate cancer	9.29e-07	5e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—AKT1—prostate cancer	9.28e-07	5e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—HPGDS—prostate cancer	9.28e-07	5e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—STAT3—prostate cancer	9.23e-07	4.97e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP2C19—prostate cancer	9.22e-07	4.97e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ESR1—prostate cancer	9.21e-07	4.96e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL6—prostate cancer	9.19e-07	4.95e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PIK3CA—prostate cancer	9.19e-07	4.95e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CDKN1B—prostate cancer	9.18e-07	4.94e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MMP9—prostate cancer	9.17e-07	4.94e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CD—prostate cancer	9.15e-07	4.93e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CTNNB1—prostate cancer	9.15e-07	4.93e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CDKN1A—prostate cancer	9.14e-07	4.92e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PIK3CB—prostate cancer	9.13e-07	4.92e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PTEN—prostate cancer	9.12e-07	4.91e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EP300—prostate cancer	9.07e-07	4.89e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—IL6—prostate cancer	9.06e-07	4.88e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTGS2—prostate cancer	9.04e-07	4.87e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GSTT1—prostate cancer	9e-07	4.85e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ACHE—prostate cancer	9e-07	4.85e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—BAD—prostate cancer	8.99e-07	4.84e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL2—prostate cancer	8.98e-07	4.84e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CDKN1B—prostate cancer	8.94e-07	4.81e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CDKN1A—prostate cancer	8.93e-07	4.81e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PTEN—prostate cancer	8.91e-07	4.8e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—AKT1—prostate cancer	8.9e-07	4.79e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP2A6—prostate cancer	8.9e-07	4.79e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—SRC—prostate cancer	8.82e-07	4.75e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL6—prostate cancer	8.81e-07	4.75e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	8.73e-07	4.7e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—APC—prostate cancer	8.7e-07	4.69e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CG—prostate cancer	8.7e-07	4.69e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EP300—prostate cancer	8.7e-07	4.68e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CTNNB1—prostate cancer	8.67e-07	4.67e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—AKR1C3—prostate cancer	8.65e-07	4.66e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—NOS3—prostate cancer	8.64e-07	4.65e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PRKACB—prostate cancer	8.61e-07	4.64e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EGF—prostate cancer	8.6e-07	4.63e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IRS1—prostate cancer	8.6e-07	4.63e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—VEGFA—prostate cancer	8.59e-07	4.63e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MYC—prostate cancer	8.58e-07	4.62e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TGFB1—prostate cancer	8.56e-07	4.61e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP17A1—prostate cancer	8.52e-07	4.59e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—STAT3—prostate cancer	8.51e-07	4.58e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EP300—prostate cancer	8.5e-07	4.58e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—IL6—prostate cancer	8.49e-07	4.57e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—AKT1—prostate cancer	8.48e-07	4.57e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CDKN1A—prostate cancer	8.47e-07	4.56e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—SRC—prostate cancer	8.46e-07	4.56e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PTEN—prostate cancer	8.45e-07	4.55e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CTNNB1—prostate cancer	8.44e-07	4.55e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.43e-07	4.54e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EGFR—prostate cancer	8.39e-07	4.52e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—AKT1—prostate cancer	8.36e-07	4.5e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—GSK3B—prostate cancer	8.35e-07	4.5e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—SRC—prostate cancer	8.27e-07	4.45e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CDKN1A—prostate cancer	8.25e-07	4.44e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—INS—prostate cancer	8.24e-07	4.44e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—VEGFA—prostate cancer	8.24e-07	4.44e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTEN—prostate cancer	8.23e-07	4.43e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—STAT3—prostate cancer	8.16e-07	4.39e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—IL6—prostate cancer	8.14e-07	4.38e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—AKT1—prostate cancer	8.13e-07	4.38e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NCOA2—prostate cancer	8.12e-07	4.37e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CREBBP—prostate cancer	8.07e-07	4.35e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EP300—prostate cancer	8.06e-07	4.34e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CB—prostate cancer	7.98e-07	4.3e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—STAT3—prostate cancer	7.97e-07	4.29e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IGF1—prostate cancer	7.97e-07	4.29e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—EGFR—prostate cancer	7.93e-07	4.27e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KRAS—prostate cancer	7.93e-07	4.27e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MYC—prostate cancer	7.91e-07	4.26e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTGS2—prostate cancer	7.9e-07	4.26e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TGFB1—prostate cancer	7.89e-07	4.25e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTEN—prostate cancer	7.89e-07	4.25e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EP300—prostate cancer	7.85e-07	4.23e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—SRC—prostate cancer	7.84e-07	4.22e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—AKT1—prostate cancer	7.83e-07	4.22e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—SLC5A5—prostate cancer	7.74e-07	4.17e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EGFR—prostate cancer	7.73e-07	4.16e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MAP2K1—prostate cancer	7.7e-07	4.15e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PIK3CA—prostate cancer	7.69e-07	4.14e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CD—prostate cancer	7.65e-07	4.12e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—SRC—prostate cancer	7.63e-07	4.11e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—PIK3CA—prostate cancer	7.58e-07	4.08e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MYC—prostate cancer	7.58e-07	4.08e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SERPINE1—prostate cancer	7.57e-07	4.08e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP2E1—prostate cancer	7.56e-07	4.07e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TGFB1—prostate cancer	7.56e-07	4.07e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—STAT3—prostate cancer	7.56e-07	4.07e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—EP300—prostate cancer	7.52e-07	4.05e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—AKT1—prostate cancer	7.51e-07	4.04e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—KRAS—prostate cancer	7.49e-07	4.03e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NQO1—prostate cancer	7.48e-07	4.03e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EGFR—prostate cancer	7.41e-07	3.99e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—TH—prostate cancer	7.37e-07	3.97e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MYC—prostate cancer	7.37e-07	3.97e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—STAT3—prostate cancer	7.36e-07	3.96e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—FGF2—prostate cancer	7.33e-07	3.95e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KRAS—prostate cancer	7.3e-07	3.93e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP3A4—prostate cancer	7.29e-07	3.93e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PIK3CA—prostate cancer	7.28e-07	3.92e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EGFR—prostate cancer	7.25e-07	3.9e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NOS3—prostate cancer	7.23e-07	3.89e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP1B1—prostate cancer	7.17e-07	3.86e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—prostate cancer	7.05e-07	3.8e-06	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PIK3CA—prostate cancer	7.04e-07	3.79e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—JAK2—prostate cancer	7.02e-07	3.78e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KRAS—prostate cancer	7e-07	3.77e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GGT1—prostate cancer	6.94e-07	3.74e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTEN—prostate cancer	6.89e-07	3.71e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—PIK3CA—prostate cancer	6.88e-07	3.71e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EGFR—prostate cancer	6.87e-07	3.7e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MDM2—prostate cancer	6.86e-07	3.69e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KRAS—prostate cancer	6.85e-07	3.69e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NCOA1—prostate cancer	6.84e-07	3.68e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MYC—prostate cancer	6.84e-07	3.68e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—TGFB1—prostate cancer	6.82e-07	3.67e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ERBB2—prostate cancer	6.76e-07	3.64e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP19A1—prostate cancer	6.74e-07	3.63e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PIK3CA—prostate cancer	6.71e-07	3.61e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EGFR—prostate cancer	6.69e-07	3.6e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CB—prostate cancer	6.67e-07	3.59e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—EP300—prostate cancer	6.57e-07	3.54e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—RXRA—prostate cancer	6.51e-07	3.5e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—prostate cancer	6.49e-07	3.5e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KRAS—prostate cancer	6.49e-07	3.49e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL6—prostate cancer	6.45e-07	3.47e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PIK3CA—prostate cancer	6.43e-07	3.47e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCL8—prostate cancer	6.41e-07	3.45e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KRAS—prostate cancer	6.32e-07	3.4e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PIK3CA—prostate cancer	6.29e-07	3.39e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—AKT1—prostate cancer	6.29e-07	3.39e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—COMT—prostate cancer	6.27e-07	3.38e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CDKN1B—prostate cancer	6.26e-07	3.37e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GSTP1—prostate cancer	6.24e-07	3.36e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—prostate cancer	6.22e-07	3.35e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ITPR1—prostate cancer	6.14e-07	3.31e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CASP3—prostate cancer	6.13e-07	3.3e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL2—prostate cancer	6.13e-07	3.3e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL6—prostate cancer	6.09e-07	3.28e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCND1—prostate cancer	5.97e-07	3.22e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PIK3CA—prostate cancer	5.96e-07	3.21e-06	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—AKT1—prostate cancer	5.95e-07	3.2e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL6—prostate cancer	5.94e-07	3.2e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CTNNB1—prostate cancer	5.91e-07	3.18e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PIK3CA—prostate cancer	5.81e-07	3.13e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—TYMS—prostate cancer	5.8e-07	3.12e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MMP9—prostate cancer	5.8e-07	3.12e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CDKN1A—prostate cancer	5.78e-07	3.11e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTEN—prostate cancer	5.76e-07	3.1e-06	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—AKT1—prostate cancer	5.75e-07	3.1e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GSTM1—prostate cancer	5.73e-07	3.09e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL6—prostate cancer	5.7e-07	3.07e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—LPL—prostate cancer	5.63e-07	3.03e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL6—prostate cancer	5.57e-07	3e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PIK3CA—prostate cancer	5.56e-07	3e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EP300—prostate cancer	5.5e-07	2.96e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—AKT1—prostate cancer	5.48e-07	2.95e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP1A1—prostate cancer	5.43e-07	2.93e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ERCC2—prostate cancer	5.39e-07	2.9e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SRC—prostate cancer	5.35e-07	2.88e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL6—prostate cancer	5.28e-07	2.84e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—AKT1—prostate cancer	5.26e-07	2.83e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—VEGFA—prostate cancer	5.21e-07	2.8e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—STAT3—prostate cancer	5.15e-07	2.78e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—IL6—prostate cancer	5.14e-07	2.77e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—MTHFR—prostate cancer	5.07e-07	2.73e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PPARA—prostate cancer	4.97e-07	2.68e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—AKT1—prostate cancer	4.87e-07	2.62e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CA—prostate cancer	4.86e-07	2.62e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MYC—prostate cancer	4.79e-07	2.58e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TGFB1—prostate cancer	4.78e-07	2.57e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EGFR—prostate cancer	4.68e-07	2.52e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CAV1—prostate cancer	4.67e-07	2.52e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—AKT1—prostate cancer	4.54e-07	2.45e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KRAS—prostate cancer	4.43e-07	2.38e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CG—prostate cancer	4.26e-07	2.29e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CA—prostate cancer	4.07e-07	2.19e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—INS—prostate cancer	4.03e-07	2.17e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CREBBP—prostate cancer	3.95e-07	2.13e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—prostate cancer	3.93e-07	2.12e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CD—prostate cancer	3.74e-07	2.02e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL6—prostate cancer	3.6e-07	1.94e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NOS3—prostate cancer	3.53e-07	1.9e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CB—prostate cancer	3.26e-07	1.76e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTGS2—prostate cancer	3.23e-07	1.74e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTEN—prostate cancer	2.82e-07	1.52e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—EP300—prostate cancer	2.69e-07	1.45e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CA—prostate cancer	1.99e-07	1.07e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—AKT1—prostate cancer	1.62e-07	8.75e-07	CbGpPWpGaD
